[HTML] nejm.org

[HTML][HTML] Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

B Cao, Y Wang, H Lu, C Huang, Y Yang… - … England Journal of …, 2024 - Mass Medical Soc
Background Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been
found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 …
被引用次数：13 相关文章

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

B Cao, Y Wang, H Lu, C Huang… - The New England …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Simnotrelvir is an oral 3-chymotrypsin-like protease inhibitor that has been
found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 …

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.

B Cao, Y Wang, H Lu, C Huang, Y Yang… - The New England …, 2024 - europepmc.org
Simnotrelvir is an oral 3-chymotrypsin-like protease inhibitor that has been found to have in
vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and …
[PDF] amazonaws.com

[PDF][PDF] Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

B Cao, Y Wang, H Lu, C Huang… - N Engl J …, 2024 - myvax.com.s3.amazonaws.com
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 Page 1 The new
england journal of medicine n engl j med 390;3 nejm.org January 18, 2024 230 The authors’ …